{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:04:43Z","timestamp":1774551883795,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ajog.2015.12.054","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T01:46:56Z","timestamp":1454032016000},"page":"374.e1-374.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth"],"prefix":"10.1016","volume":"214","author":[{"given":"Lynn M.","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allie","family":"Sakowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle R.","family":"Bolden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.12.054_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Prediction and prevention of preterm birth. Practice bulletin no. 130","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.12.054_bib3","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.12.054_bib4","first-page":"280","article-title":"Use of progesterone to prevent preterm birth at a tertiary care center","volume":"52","author":"Bailit","year":"2007","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2015.12.054_bib5","article-title":"Patient characteristics associated with 17-alpha-hydroxyprogesterone caproate use among a high-risk cohort","author":"Turitz","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib6","doi-asserted-by":"crossref","first-page":"262.e1","DOI":"10.1016\/j.ajog.2007.06.032","article-title":"Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting","volume":"197","author":"Rittenberg","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib7","article-title":"Pregnancy outcomes of managed Medicaid members prescribed home administration of 17 alpha-hydroxyprogesterone caproate","volume":"29","author":"Lucas","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2015.12.054_bib8","doi-asserted-by":"crossref","first-page":"224.e1","DOI":"10.1016\/j.ajog.2007.01.002","article-title":"Increased recurrence of preterm delivery with early cessation of 17 alpha-hydroxyprogesterone caproate","volume":"196","author":"Rebarber","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib9","first-page":"47","article-title":"Optimizing the use of 17P in pregnant managed Medicaid members","volume":"17","author":"Mason","year":"2008","journal-title":"Managed Care"},{"key":"10.1016\/j.ajog.2015.12.054_bib10","first-page":"55","article-title":"Spontaneous preterm birth in African American and Caucasian women receiving 17 alpha-hydroxyprogesterone caproate","volume":"31","author":"Timofeev","year":"2014","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2015.12.054_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","author":"Berghella","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ajog.2005.05.077","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery","volume":"193","author":"Spong","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.054_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.AOG.0000174582.79364.a7","article-title":"Does progesterone treatment influence risk factors for recurrent preterm delivery?","volume":"106","author":"Meis","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815026587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815026587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:08:58Z","timestamp":1757588938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815026587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002937815026587"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.12.054","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.12.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}